380 related articles for article (PubMed ID: 26994869)
1. Clinical challenge: An orbital Hickam's dictum.
Wilson ME; Thornton S; Murchison AP; Bilyk JR
Surv Ophthalmol; 2016; 61(6):799-805. PubMed ID: 26994869
[TBL] [Abstract][Full Text] [Related]
2. Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.
Nagy EV; Toth J; Kaldi I; Damjanovich J; Mezosi E; Lenkey A; Toth L; Szabo J; Karanyi Z; Leovey A
Eur J Endocrinol; 2000 Jun; 142(6):591-7. PubMed ID: 10832104
[TBL] [Abstract][Full Text] [Related]
3. Pure eye muscle involvement in endocrine orbitopathy.
Gerlach M; Ferbert A
Eur Neurol; 2008; 60(2):67-72. PubMed ID: 18480610
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric proptosis in thyroid eye disease.
Rana K; Garg D; Yong LSS; Leyden J; Patel S; Slattery J; Davis G; Chan WO; Selva D
Int Ophthalmol; 2024 Apr; 44(1):206. PubMed ID: 38678129
[TBL] [Abstract][Full Text] [Related]
5. Isolated lateral rectus muscle involvement as a presenting sign of euthyroid Graves disease.
Erdurmus M; Celebi S; Ozmen S; Bucak YY
J AAPOS; 2011 Aug; 15(4):395-7. PubMed ID: 21907126
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic orbital hemorrhage related to the inferior rectus muscle: a rare cause for acute-onset diplopia and unilateral proptosis.
Ben Simon GJ; McNab AA
Ophthalmology; 2005 Oct; 112(10):1838-43. PubMed ID: 16095703
[TBL] [Abstract][Full Text] [Related]
7. Primary orbital liposarcoma misdiagnosed as thyroid associated orbitopathy.
Shinder R; Mostafavi D; Nasser QJ; Esmaeli B; Shore JW
Orbit; 2012 Aug; 31(4):264-6. PubMed ID: 22571512
[TBL] [Abstract][Full Text] [Related]
8. Changes of orbital tissue volumes and proptosis in patients with thyroid extraocular muscle swelling after methylprednisolone pulse therapy.
Higashiyama T; Nishida Y; Ohji M
Jpn J Ophthalmol; 2015 Nov; 59(6):430-5. PubMed ID: 26321629
[TBL] [Abstract][Full Text] [Related]
9. Age-related difference in extraocular muscles and its relation to clinical manifestations in an ethnically homogenous group of patients with Graves' orbitopathy.
Su Y; Liu X; Fang S; Huang Y; Li Y; Zhong S; Wang Y; Zhang S; Zhou H; Sun J; Fan X
Graefes Arch Clin Exp Ophthalmol; 2022 Feb; 260(2):583-589. PubMed ID: 34477926
[TBL] [Abstract][Full Text] [Related]
10. The challenge of orbital decompression in a patient with multiple autoimmune diseases and graves' orbitopathy: a case report and review of literature.
Sellari-Franceschini S; Bartalena L; Seccia V
Orbit; 2010 Feb; 29(1):48-50. PubMed ID: 20302412
[TBL] [Abstract][Full Text] [Related]
11. Thyroid eye disease presenting with superior rectus/levator complex enlargement.
Wang Y; Mettu P; Broadbent T; Radke P; Firl K; Shepherd JB; Couch SM; Nguyen A; Henderson AD; McCulley T; McClelland CM; Mokhtarzadeh A; Lee MS; Garrity JA; Harrison AR
Orbit; 2020 Feb; 39(1):5-12. PubMed ID: 31056988
[No Abstract] [Full Text] [Related]
12. Exophthalmos in a young woman with no graves' disease - a case report of IgG4-related orbitopathy.
Erdei A; Steiber Z; Molnar C; Berenyi E; Nagy EV
BMC Ophthalmol; 2018 Jan; 18(1):5. PubMed ID: 29329570
[TBL] [Abstract][Full Text] [Related]
13. Orbital fat decompression for thyroid eye disease: retrospective case review and criteria for optimal case selection.
Prat MC; Braunstein AL; Dagi Glass LR; Kazim M
Ophthalmic Plast Reconstr Surg; 2015; 31(3):215-8. PubMed ID: 25198394
[TBL] [Abstract][Full Text] [Related]
14. Echographic Assessment of Extraocular Muscle Response to Teprotumumab.
Tran C; Pham CM; Simmons BA; Warner LL; Fuhrmeister LJ; Shriver EM
Ophthalmic Plast Reconstr Surg; 2022 Jul-Aug 01; 38(4):336-339. PubMed ID: 34652310
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of exophthalmos using orbital ultrasonography and treatment of malignant exophthalmos with steroid therapy, orbital radiation therapy, and plasmapheresis.
Yamamoto K; Saito K; Takai T; Yoshida S
Prog Clin Biol Res; 1983; 116():189-205. PubMed ID: 6134291
[TBL] [Abstract][Full Text] [Related]
16. Reduction in Extraocular Muscle Cross-sectional Area and Correlation With Extraocular Motility and Diplopia Following Teprotumumab for Thyroid Eye Disease.
Reshef ER; Marsiglia M; Bouhadjer K; Chiou CA; O'Brien-Coon D; Reinshagen KL; Freitag SK
Ophthalmic Plast Reconstr Surg; 2023 Sep-Oct 01; 39(5):433-439. PubMed ID: 36852831
[TBL] [Abstract][Full Text] [Related]
17. Occult thyroid eye disease in patients with unexplained ocular misalignment identified by standardized orbital echography.
Volpe NJ; Sbarbaro JA; Gendron Livingston K; Galetta SL; Liu GT; Balcer LJ
Am J Ophthalmol; 2006 Jul; 142(1):75-81. PubMed ID: 16815253
[TBL] [Abstract][Full Text] [Related]
18. Extraocular muscle expansion after deep lateral orbital wall decompression: influence on proptosis reduction and its predictive factors.
Lee PAL; Vaidya A; Kono S; Kakizaki H; Takahashi Y
Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3427-3435. PubMed ID: 34164724
[TBL] [Abstract][Full Text] [Related]
19. Bilateral optic nerve edema presenting as initial manifestation of thyroid eye disease.
Wilson ME; Kim C; Carrasco J
Orbit; 2016 Oct; 35(5):288-91. PubMed ID: 27486810
[TBL] [Abstract][Full Text] [Related]
20. A case of bilateral amyloidosis localized to extraocular muscles mimicking thyroid eye disease.
Yoshida-Hata N; Mimura M; Aikawa M; Kashima T
BMC Ophthalmol; 2024 Jan; 24(1):42. PubMed ID: 38279160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
